The Gross Margin of Newron Pharmaceuticals SpA (NWRN.SW) is 98.26%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 98.26% |
| 2023-12-31 | 94.80% |
| 2022-12-31 | 92.73% |
| 2021-12-31 | 97.97% |
| 2020-12-31 | 94.39% |
| 2019-12-31 | 79.75% |
| 2018-12-31 | 65.91% |
| 2017-12-31 | 88.14% |
| 2016-12-31 | 44.40% |
| 2015-12-31 | 44.53% |